AM-PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AM-PHARMA
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Other debts +€118,706
up €118,706 (+18.8%), from €632,447 to €751,153
- Current portion of long-term debt -€46,916
down €46,916 (-70.2%), from €66,811 to €19,895
- Reserves -€38,840
down €38,840 (-10.2%), from €382,233 to €343,393
- Debts after one year -€18,373
down €18,373 (-11.6%), from €158,414 to €140,041
- Gross operating margin -€115,366
down €115,366, from €106,052 to -€9,314
- Taxes -€13,498
down €13,498 (-100.0%), from €13,498 to €0
- Financial charges -€8,532
down €8,532 (-23.1%), from €36,931 to €28,400
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,422,026 | €1,420,162 | -€1,865 | -0.1% |
| Fixed assets | 21/28 | €1,415,479 | €1,415,479 | = | 0.0% |
| Financial fixed assets | 28 | €1,415,479 | €1,415,479 | = | 0.0% |
| Current assets | 29/58 | €6,548 | €4,683 | -€1,865 | -28.5% |
| Amounts receivable within one year | 40/41 | €462 | €0 | -€462 | -100.0% |
| Trade receivables | 40 | €462 | €0 | -€462 | -100.0% |
| Cash at bank and in hand | 54/58 | €5,344 | €3,930 | -€1,414 | -26.5% |
| Deferred charges and accrued income | 490/1 | €742 | €753 | +€11 | +1.5% |
| Total equity and liabilities | 10/49 | €1,422,026 | €1,420,162 | -€1,865 | -0.1% |
| Equity | 10/15 | €532,233 | €493,393 | -€38,840 | -7.3% |
| Contributions | 10/11 | €150,000 | €150,000 | = | 0.0% |
| Reserves | 13 | €382,233 | €343,393 | -€38,840 | -10.2% |
| Distributable reserves | 133 | €382,233 | €343,393 | -€38,840 | -10.2% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €889,793 | €926,769 | +€36,976 | +4.2% |
| Amounts payable after more than one year | 17 | €158,414 | €140,041 | -€18,373 | -11.6% |
| Financial debts | 170/4 | €158,414 | €140,041 | -€18,373 | -11.6% |
| Amounts payable within one year | 42/48 | €715,352 | €780,301 | +€64,950 | +9.1% |
| Current portion of amounts payable after more than one year | 42 | €66,811 | €19,895 | -€46,916 | -70.2% |
| Financial debts | 43 | €4,397 | €0 | -€4,397 | -100.0% |
| Credit institutions | 430/8 | €4,397 | €0 | -€4,397 | -100.0% |
| Trade debts | 44 | €1,915 | €2,009 | +€95 | +4.9% |
| Suppliers | 440/4 | €1,915 | €2,009 | +€95 | +4.9% |
| Taxes, remuneration and social security | 45 | €9,782 | €7,244 | -€2,538 | -25.9% |
| Taxes | 450/3 | €9,782 | €7,244 | -€2,538 | -25.9% |
| Other amounts payable | 47/48 | €632,447 | €751,153 | +€118,706 | +18.8% |
| Accrued charges and deferred income | 492/3 | €16,028 | €6,427 | -€9,601 | -59.9% |
| Non-recurring operating income | 76A | €5,598 | €0 | -€5,598 | -100.0% |
| Other operating charges | 640/8 | €1,147 | €1,126 | -€20 | -1.8% |
| Non-recurring operating charges | 66A | €0 | - | = | |
| Gross operating margin | 9900 | €106,052 | -€9,314 | -€115,366 | |
| Operating profit (loss) | 9901 | €104,905 | -€10,441 | -€115,346 | |
| Financial charges | 65/66B | €36,931 | €28,400 | -€8,532 | -23.1% |
| Recurring financial charges | 65 | €36,931 | €28,400 | -€8,532 | -23.1% |
| Profit (loss) for the period before taxes | 9903 | €67,974 | -€38,840 | -€106,814 | |
| Income taxes | 67/77 | €13,498 | €0 | -€13,498 | -100.0% |
| Profit (loss) for the period | 9904 | €54,476 | -€38,840 | -€93,316 | |
| Profit (loss) for the period to be appropriated | 9905 | €54,476 | -€38,840 | -€93,316 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.